These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 28278721)

  • 1. Sertraline exerts its antitumor functions through both apoptosis and autophagy pathways in acute myeloid leukemia cells.
    Xia D; Zhang YT; Xu GP; Yan WW; Pan XR; Tong JH
    Leuk Lymphoma; 2017 Sep; 58(9):1-10. PubMed ID: 28278721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T315 Decreases Acute Myeloid Leukemia Cell Viability through a Combination of Apoptosis Induction and Autophagic Cell Death.
    Chiu CF; Weng JR; Jadhav A; Wu CY; Sargeant AM; Bai LY
    Int J Mol Sci; 2016 Aug; 17(8):. PubMed ID: 27537872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of JL1037 as a novel, specific, reversible lysine-specific demethylase 1 inhibitor that induce apoptosis and autophagy of AML cells.
    Liu S; Lu W; Li S; Li S; Liu J; Xing Y; Zhang S; Zhou JZ; Xing H; Xu Y; Rao Q; Deng C; Wang M; Wang J
    Oncotarget; 2017 May; 8(19):31901-31914. PubMed ID: 28404874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of chlorprothixene as a potential drug that induces apoptosis and autophagic cell death in acute myeloid leukemia cells.
    Du Y; Li K; Wang X; Kaushik AC; Junaid M; Wei D
    FEBS J; 2020 Apr; 287(8):1645-1665. PubMed ID: 31625692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting PDK1 with dichloroacetophenone to inhibit acute myeloid leukemia (AML) cell growth.
    Qin L; Tian Y; Yu Z; Shi D; Wang J; Zhang C; Peng R; Chen X; Liu C; Chen Y; Huang W; Deng W
    Oncotarget; 2016 Jan; 7(2):1395-407. PubMed ID: 26593251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of CDK4/6 and autophagy synergistically induces apoptosis in t(8;21) acute myeloid leukemia cells.
    Nakatani K; Matsuo H; Harata Y; Higashitani M; Koyama A; Noura M; Nishinaka-Arai Y; Kamikubo Y; Adachi S
    Int J Hematol; 2021 Feb; 113(2):243-253. PubMed ID: 33068248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. OSU-A9, an indole-3-carbinol derivative, induces cytotoxicity in acute myeloid leukemia through reactive oxygen species-mediated apoptosis.
    Bai LY; Weng JR; Chiu CF; Wu CY; Yeh SP; Sargeant AM; Lin PH; Liao YM
    Biochem Pharmacol; 2013 Nov; 86(10):1430-40. PubMed ID: 24041743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of celecoxib and doxorubicin increases growth inhibition and apoptosis in acute myeloid leukemia cells.
    Chen C; Xu W; Wang CM
    Leuk Lymphoma; 2013 Nov; 54(11):2517-22. PubMed ID: 23452119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A synthetic cell-penetrating peptide derived from nuclear localization signal of EPS8 exerts anticancer activity against acute myeloid leukemia.
    Chen Y; Xie X; Wu A; Wang L; Hu Y; Zhang H; Li Y
    J Exp Clin Cancer Res; 2018 Jan; 37(1):12. PubMed ID: 29357910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radotinib inhibits acute myeloid leukemia cell proliferation via induction of mitochondrial-dependent apoptosis and CDK inhibitors.
    Heo SK; Noh EK; Gwon GD; Kim JY; Jo JC; Choi Y; Koh S; Baek JH; Min YJ; Kim H
    Eur J Pharmacol; 2016 Oct; 789():280-290. PubMed ID: 27477352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Typhaneoside prevents acute myeloid leukemia (AML) through suppressing proliferation and inducing ferroptosis associated with autophagy.
    Zhu HY; Huang ZX; Chen GQ; Sheng F; Zheng YS
    Biochem Biophys Res Commun; 2019 Sep; 516(4):1265-1271. PubMed ID: 31301767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blocking autophagy enhanced leukemia cell death induced by recombinant human arginase.
    Li Y; Zeng X; Wang S; Fan J; Wang Z; Song P; Mei X; Ju D
    Tumour Biol; 2016 May; 37(5):6627-35. PubMed ID: 26643895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Celecoxib exerts antitumor effects in HL-60 acute leukemia cells and inhibits autophagy by affecting lysosome function.
    Lu Y; Liu XF; Liu TR; Fan RF; Xu YC; Zhang XZ; Liu LL
    Biomed Pharmacother; 2016 Dec; 84():1551-1557. PubMed ID: 27884749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel small molecule SIRT2 inhibitors induce cell death in leukemic cell lines.
    Kozako T; Mellini P; Ohsugi T; Aikawa A; Uchida YI; Honda SI; Suzuki T
    BMC Cancer; 2018 Aug; 18(1):791. PubMed ID: 30081901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The simultaneous inhibition of the mTOR and MAPK pathways with Gnetin-C induces apoptosis in acute myeloid leukemia.
    Espinoza JL; Elbadry MI; Taniwaki M; Harada K; Trung LQ; Nakagawa N; Takami A; Ishiyama K; Yamauchi T; Takenaka K; Nakao S
    Cancer Lett; 2017 Aug; 400():127-136. PubMed ID: 28456658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MAP30 inhibits autophagy through enhancing acetyltransferase p300 and induces apoptosis in acute myeloid leukemia cells.
    Qian S; Sun L; Li J; Wu J; Hu G; Han Y; Yu K; Zhang S
    Oncol Rep; 2016 Jun; 35(6):3705-13. PubMed ID: 27035419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AMPK-ULK1-Mediated Autophagy Confers Resistance to BET Inhibitor JQ1 in Acute Myeloid Leukemia Stem Cells.
    Jang JE; Eom JI; Jeung HK; Cheong JW; Lee JY; Kim JS; Min YH
    Clin Cancer Res; 2017 Jun; 23(11):2781-2794. PubMed ID: 27864418
    [No Abstract]   [Full Text] [Related]  

  • 18. Targeting AMPK-ULK1-mediated autophagy for combating BET inhibitor resistance in acute myeloid leukemia stem cells.
    Jang JE; Eom JI; Jeung HK; Cheong JW; Lee JY; Kim JS; Min YH
    Autophagy; 2017 Apr; 13(4):761-762. PubMed ID: 28118076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imipridone ONC212 activates orphan G protein-coupled receptor GPR132 and integrated stress response in acute myeloid leukemia.
    Nii T; Prabhu VV; Ruvolo V; Madhukar N; Zhao R; Mu H; Heese L; Nishida Y; Kojima K; Garnett MJ; McDermott U; Benes CH; Charter N; Deacon S; Elemento O; Allen JE; Oster W; Stogniew M; Ishizawa J; Andreeff M
    Leukemia; 2019 Dec; 33(12):2805-2816. PubMed ID: 31127149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The dual mTORC1 and mTORC2 inhibitor AZD8055 has anti-tumor activity in acute myeloid leukemia.
    Willems L; Chapuis N; Puissant A; Maciel TT; Green AS; Jacque N; Vignon C; Park S; Guichard S; Herault O; Fricot A; Hermine O; Moura IC; Auberger P; Ifrah N; Dreyfus F; Bonnet D; Lacombe C; Mayeux P; Bouscary D; Tamburini J
    Leukemia; 2012 Jun; 26(6):1195-202. PubMed ID: 22143671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.